Boaz Wachtel

Boaz Wachtel is a certified clinical research manager and holds an MA in management and marketing from the University of Maryland. He was co-founder and former managing director of Phytotech Medical, Australia's first publicly traded medical cannabis company. He is also the co-founder of IMCPC - International Medical Cannabis Patient Coalition. Mr Wachtel is an Israeli medical cannabis pioneer/activist, who formulated and assisted the Ministry of Health with the implementation of the National Medical Cannabis Program which is one of only three national programs in the world. He is a frequent lecturer and adviser to governments, national committees, business and NGOs on medical cannabis program formulation, grow operations, international laws and UN drug convention compliance, as well as the founder and former chair of the Green Leaf Party, a political party for cannabis legalisation/medicalisation, human rights and ecology. Mr Wachtel is the co-author of the Ibogaine - Treatment Manual and has published more than 25 articles, papers and three book chapters.
Bio last updated 08 Dec 2018

Access to our data for Boaz Wachtel is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Boaz Wachtel is linked to 3 organisations which are included in 1 list - Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 30/11/18

1 year TSR5 year TSR
163rdQueste Communications21%-5%
748thCreso Pharma-64%0%
801stRace Oncology-75%0%
741 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


Co-Founder, Non-Executive Chairman
Co-Founder, R&D and Business Development
Year started and most recent title

Share Transactions

$2k Bought
$480k Bought
$60k Bought
Total value as at the date of the transaction
Source: Morningstar


189th↑Creso Pharma$244k
190th↓Wavenet International$239k
193rd↓Queste Communications$172k
194th-Race Oncology$170k
238 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer